HEADER TRANSCRIPTION/TRANSFERASE 12-FEB-09 3G8I
TITLE ALEGLITAZAR, A NEW, POTENT, AND BALANCED PPAR ALPHA/GAMMA AGONIST FOR
TITLE 2 THE TREATMENT OF TYPE II DIABETES
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA;
COMPND 3 CHAIN: A;
COMPND 4 FRAGMENT: LIGAND BIND DOMAIN;
COMPND 5 SYNONYM: PPAR-ALPHA, NUCLEAR RECEPTOR SUBFAMILY 1 GROUP C MEMBER 1;
COMPND 6 ENGINEERED: YES;
COMPND 7 MOL_ID: 2;
COMPND 8 MOLECULE: NUCLEAR RECEPTOR COACTIVATOR 1;
COMPND 9 CHAIN: Z;
COMPND 10 FRAGMENT: MOTIF 5;
COMPND 11 SYNONYM: COACTIVATOR PEPTIDE SRC-1, NCOA-1, STEROID RECEPTOR
COMPND 12 COACTIVATOR 1, SRC-1, RIP160, PROTEIN HIN-2, RENAL CARCINOMA ANTIGEN
COMPND 13 NY-REN-52;
COMPND 14 EC: 2.3.1.48;
COMPND 15 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: PPARA, NR1C1, PPAR;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562;
SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET15B;
SOURCE 10 MOL_ID: 2;
SOURCE 11 SYNTHETIC: YES;
SOURCE 12 OTHER_DETAILS: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED. THE SEQUENCE
SOURCE 13 OF THE PEPTIDE IS NATURALLY FOUND IN HOMO SAPIENS (HUMAN)
KEYWDS NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION FACTOR, DIABETES, ACTIVATOR,
KEYWDS 2 DNA-BINDING, METAL-BINDING, NUCLEUS, POLYMORPHISM, RECEPTOR,
KEYWDS 3 TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER,
KEYWDS 4 ACYLTRANSFERASE, ALTERNATIVE SPLICING, CHROMOSOMAL REARRANGEMENT,
KEYWDS 5 PHOSPHOPROTEIN, PROTO-ONCOGENE, TRANSFERASE, UBL CONJUGATION,
KEYWDS 6 TRANSCRIPTION-TRANSFERASE COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR J.BENZ,A.BERNARDEAU,A.BINGGELI,D.BLUM,M.BOEHRINGER,U.GRETHER,
AUTHOR 2 H.HILPERT,B.KUHN,H.P.MAERKI,M.MEYER,K.PUENTENER,S.RAAB,A.RUF,
AUTHOR 3 D.SCHLATTER,B.GSELL,M.STIHLE,P.MOHR
REVDAT 2 01-NOV-23 3G8I 1 REMARK
REVDAT 1 02-JUN-09 3G8I 0
JRNL AUTH A.BENARDEAU,J.BENZ,A.BINGGELI,D.BLUM,M.BOEHRINGER,U.GRETHER,
JRNL AUTH 2 H.HILPERT,B.KUHN,H.P.MARKI,M.MEYER,K.PUNTENER,S.RAAB,A.RUF,
JRNL AUTH 3 D.SCHLATTER,P.MOHR
JRNL TITL ALEGLITAZAR, A NEW, POTENT, AND BALANCED DUAL
JRNL TITL 2 PPARALPHA/GAMMA AGONIST FOR THE TREATMENT OF TYPE II
JRNL TITL 3 DIABETES.
JRNL REF BIOORG.MED.CHEM.LETT. V. 19 2468 2009
JRNL REFN ISSN 0960-894X
JRNL PMID 19349176
JRNL DOI 10.1016/J.BMCL.2009.03.036
REMARK 2
REMARK 2 RESOLUTION. 2.20 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : REFMAC 5.1.24
REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK 3 : NICHOLLS,WINN,LONG,VAGIN
REMARK 3
REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 15.00
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 97.3
REMARK 3 NUMBER OF REFLECTIONS : 15390
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.202
REMARK 3 R VALUE (WORKING SET) : 0.199
REMARK 3 FREE R VALUE : 0.261
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100
REMARK 3 FREE R VALUE TEST SET COUNT : 823
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 20
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.26
REMARK 3 REFLECTION IN BIN (WORKING SET) : 994
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL
REMARK 3 BIN R VALUE (WORKING SET) : 0.2320
REMARK 3 BIN FREE R VALUE SET COUNT : 55
REMARK 3 BIN FREE R VALUE : 0.2750
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 2103
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 31
REMARK 3 SOLVENT ATOMS : 155
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.36
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 1.53000
REMARK 3 B22 (A**2) : -2.70000
REMARK 3 B33 (A**2) : 1.16000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED OVERALL COORDINATE ERROR.
REMARK 3 ESU BASED ON R VALUE (A): 0.273
REMARK 3 ESU BASED ON FREE R VALUE (A): 0.228
REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.159
REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.210
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.942
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.908
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT
REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2176 ; 0.018 ; 0.022
REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL
REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2929 ; 1.684 ; 1.993
REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL
REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 258 ; 4.993 ; 5.000
REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL
REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL
REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL
REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 335 ; 0.101 ; 0.200
REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1589 ; 0.004 ; 0.020
REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1064 ; 0.249 ; 0.300
REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 229 ; 0.257 ; 0.500
REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 23 ; 0.188 ; 0.300
REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 3 ; 0.335 ; 0.500
REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1309 ; 2.216 ; 2.000
REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2110 ; 3.531 ; 3.000
REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 867 ; 2.660 ; 2.000
REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 819 ; 3.969 ; 3.000
REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 NCS RESTRAINTS STATISTICS
REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : BABINET MODEL WITH MASK
REMARK 3 PARAMETERS FOR MASK CALCULATION
REMARK 3 VDW PROBE RADIUS : 1.40
REMARK 3 ION PROBE RADIUS : 0.80
REMARK 3 SHRINKAGE RADIUS : 0.80
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING
REMARK 3 POSITIONS
REMARK 4
REMARK 4 3G8I COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 18-FEB-09.
REMARK 100 THE DEPOSITION ID IS D_1000051556.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 13-OCT-02
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 8.5
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : N
REMARK 200 RADIATION SOURCE : ROTATING ANODE
REMARK 200 BEAMLINE : NULL
REMARK 200 X-RAY GENERATOR MODEL : OTHER
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : IMAGE PLATE
REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 300 MM PLATE
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO
REMARK 200 DATA SCALING SOFTWARE : SCALEPACK
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16293
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200
REMARK 200 RESOLUTION RANGE LOW (A) : 20.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 97.5
REMARK 200 DATA REDUNDANCY : 4.700
REMARK 200 R MERGE (I) : 0.06000
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 19.2000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28
REMARK 200 COMPLETENESS FOR SHELL (%) : 92.5
REMARK 200 DATA REDUNDANCY IN SHELL : 4.70
REMARK 200 R MERGE FOR SHELL (I) : 0.33200
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.200
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: AMORE
REMARK 200 STARTING MODEL: 1K71
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 50.06
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.46
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 20-22% PEG 2000, 0.2M NACL, 5%
REMARK 280 GLYCEROL, 0.1M TRIS-CL, PH 8.5, VAPOR DIFFUSION, TEMPERATURE 293K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 21.20250
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 49.24750
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.01650
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 49.24750
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.20250
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 38.01650
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 1080 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 13250 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, Z
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLU A 199
REMARK 465 THR A 200
REMARK 465 ALA A 201
REMARK 465 GLY A 231
REMARK 465 LYS A 232
REMARK 465 ALA A 233
REMARK 465 SER A 234
REMARK 465 ASN A 235
REMARK 465 ASN A 236
REMARK 465 VAL A 259
REMARK 465 ALA A 260
REMARK 465 ASN A 261
REMARK 465 GLY A 262
REMARK 465 ILE A 263
REMARK 465 GLN A 264
REMARK 465 ASN A 265
REMARK 465 LYS Z 744
REMARK 465 ASP Z 745
REMARK 465 ASP Z 754
REMARK 465 LYS Z 755
REMARK 465 ASP Z 756
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT
REMARK 500
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE
REMARK 500 N TYR A 468 O HOH A 193 1.83
REMARK 500 OD1 ASN A 219 O HOH A 192 1.86
REMARK 500 O LEU Z 753 O HOH Z 143 2.07
REMARK 500 O HOH A 37 O HOH A 196 2.11
REMARK 500 O HOH A 110 O HOH A 188 2.13
REMARK 500 O HOH A 75 O HOH A 471 2.19
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 ASP A 360 CB - CG - OD2 ANGL. DEV. = 5.5 DEGREES
REMARK 500 ARG A 434 NE - CZ - NH2 ANGL. DEV. = -3.0 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE RO7 A 1
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 3G9E RELATED DB: PDB
DBREF 3G8I A 199 468 UNP Q07869 PPARA_HUMAN 199 468
DBREF 3G8I Z 744 756 UNP Q15788 NCOA1_HUMAN 744 756
SEQRES 1 A 270 GLU THR ALA ASP LEU LYS SER LEU ALA LYS ARG ILE TYR
SEQRES 2 A 270 GLU ALA TYR LEU LYS ASN PHE ASN MET ASN LYS VAL LYS
SEQRES 3 A 270 ALA ARG VAL ILE LEU SER GLY LYS ALA SER ASN ASN PRO
SEQRES 4 A 270 PRO PHE VAL ILE HIS ASP MET GLU THR LEU CYS MET ALA
SEQRES 5 A 270 GLU LYS THR LEU VAL ALA LYS LEU VAL ALA ASN GLY ILE
SEQRES 6 A 270 GLN ASN LYS GLU ALA GLU VAL ARG ILE PHE HIS CYS CYS
SEQRES 7 A 270 GLN CYS THR SER VAL GLU THR VAL THR GLU LEU THR GLU
SEQRES 8 A 270 PHE ALA LYS ALA ILE PRO GLY PHE ALA ASN LEU ASP LEU
SEQRES 9 A 270 ASN ASP GLN VAL THR LEU LEU LYS TYR GLY VAL TYR GLU
SEQRES 10 A 270 ALA ILE PHE ALA MET LEU SER SER VAL MET ASN LYS ASP
SEQRES 11 A 270 GLY MET LEU VAL ALA TYR GLY ASN GLY PHE ILE THR ARG
SEQRES 12 A 270 GLU PHE LEU LYS SER LEU ARG LYS PRO PHE CYS ASP ILE
SEQRES 13 A 270 MET GLU PRO LYS PHE ASP PHE ALA MET LYS PHE ASN ALA
SEQRES 14 A 270 LEU GLU LEU ASP ASP SER ASP ILE SER LEU PHE VAL ALA
SEQRES 15 A 270 ALA ILE ILE CYS CYS GLY ASP ARG PRO GLY LEU LEU ASN
SEQRES 16 A 270 VAL GLY HIS ILE GLU LYS MET GLN GLU GLY ILE VAL HIS
SEQRES 17 A 270 VAL LEU ARG LEU HIS LEU GLN SER ASN HIS PRO ASP ASP
SEQRES 18 A 270 ILE PHE LEU PHE PRO LYS LEU LEU GLN LYS MET ALA ASP
SEQRES 19 A 270 LEU ARG GLN LEU VAL THR GLU HIS ALA GLN LEU VAL GLN
SEQRES 20 A 270 ILE ILE LYS LYS THR GLU SER ASP ALA ALA LEU HIS PRO
SEQRES 21 A 270 LEU LEU GLN GLU ILE TYR ARG ASP MET TYR
SEQRES 1 Z 13 LYS ASP HIS GLN LEU LEU ARG TYR LEU LEU ASP LYS ASP
HET RO7 A 1 31
HETNAM RO7 (2S)-2-METHOXY-3-{4-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-
HETNAM 2 RO7 YL)ETHOXY]-1-BENZOTHIOPHEN-7-YL}PROPANOIC ACID
FORMUL 3 RO7 C24 H23 N O5 S
FORMUL 4 HOH *155(H2 O)
HELIX 1 1 SER A 205 PHE A 218 1 14
HELIX 2 2 ASN A 221 SER A 230 1 10
HELIX 3 3 ASP A 243 LEU A 254 1 12
HELIX 4 4 GLU A 267 ILE A 294 1 28
HELIX 5 5 GLY A 296 LEU A 300 5 5
HELIX 6 6 ASP A 301 SER A 322 1 22
HELIX 7 7 ARG A 341 LEU A 347 1 7
HELIX 8 8 PHE A 351 ALA A 367 1 17
HELIX 9 9 ASP A 371 CYS A 384 1 14
HELIX 10 10 ASN A 393 HIS A 416 1 24
HELIX 11 11 PHE A 421 GLU A 451 1 31
HELIX 12 12 HIS A 457 ARG A 465 1 9
HELIX 13 13 HIS Z 746 LEU Z 753 1 8
SHEET 1 A 4 PHE A 239 ILE A 241 0
SHEET 2 A 4 GLY A 337 THR A 340 1 O PHE A 338 N PHE A 239
SHEET 3 A 4 GLY A 329 VAL A 332 -1 N MET A 330 O ILE A 339
SHEET 4 A 4 MET A 325 ASN A 326 -1 N ASN A 326 O GLY A 329
CISPEP 1 LYS A 349 PRO A 350 0 6.41
SITE 1 AC1 12 LEU A 247 VAL A 255 PHE A 273 CYS A 276
SITE 2 AC1 12 SER A 280 TYR A 314 VAL A 332 ILE A 354
SITE 3 AC1 12 MET A 355 HIS A 440 LEU A 460 TYR A 464
CRYST1 42.405 76.033 98.495 90.00 90.00 90.00 P 21 21 21 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.023582 0.000000 0.000000 0.00000
SCALE2 0.000000 0.013152 0.000000 0.00000
SCALE3 0.000000 0.000000 0.010153 0.00000